Back to the Top
The following message was posted to: PharmPK
Does anyone know of any instances, preferably published in the
literature, of assessing drug concentrations in bone marrow aspirates
(particularly the supernatant) taken at regular intervals in an AML
population? Or is the bone marrow vascularized enough that plasma
concentrations are a sufficient surrogate for drug concentration in the
marrow? I assume the latter, but any opinions or experiences on this?
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Bone marrow aspirate drug concentrations in AML" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (email@example.com)